Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Brinzolamide 1% and Brimonidine 0.2% eye drops (Simbrinza) |
Specialist ophthalmologist recommendation |
|
|
|
Brinzolamide eye drops |
Specialist ophthalmologist recommendation |
|
|
|
Brivaracetam (Briviact®) |
Initiation by Tertiary Epilepsy Specialist only. For adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age, with severe refractory epilepsy warranting tertiary specialist input for patients who have tried three or more AEDs. The patient has used levetiracetam and has documentation of intolerance and patient is using a third line agent (perampanel, zonisamide, lacosamide, eslicarbazepine) which would be replaced by brivaracetam. ESCA required. |
|
|
|
Bromonidine eye drops |
Specialist ophthalmologist recommendation |
|
|
|
Budesonide 2mg rectal foam (2mg per 1 metered dose) (Budenofalk®) |
Approved to support the shortage of Colifoam (June 2018) |
|
|
|
Budesonide capsules (Budenofalk capsules 3mg) |
Consultant initiation only |
|
|
|
Buprenorphine patches |
Specialist initiation only. Patches must be prescribed by brand. |
|
|
|
Buprenorphine S/L tablets#4.10 | ||
|
|
Cabergoline tablets | ||
|
|
Calcitriol |
